title: New GRAPPA and EULAR recommendations for the management of psoriatic arthritis.
authors.affiliation: Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds UK.
authors.forename: Laura C
authors.initials: LC
authors.lastname: Coates
authors.affiliation: Department of rheumatology, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Paris, France.
authors.forename: Laure
authors.initials: L
authors.lastname: Gossec
authors.affiliation: Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands.
authors.forename: Sofia
authors.initials: S
authors.lastname: Ramiro
authors.affiliation: Swedish Medical Center Seattle, WA, USA.
authors.forename: Philip
authors.initials: P
authors.lastname: Mease
authors.affiliation: Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands.
authors.forename: Désirée
authors.initials: D
authors.lastname: van der Heijde
authors.affiliation: Division of Rheumatology, Department of Medicine 3, Medical University of Vienna.|2nd Department of Medicine, Hietzing Hospital, Vienna, Austria.
authors.forename: Josef S
authors.initials: JS
authors.lastname: Smolen
authors.affiliation: Allergy, Immunology & Rheumatology Division, University of Rochester Medical Center, Rochester, NY.
authors.forename: Christopher
authors.initials: C
authors.lastname: Ritchlin
authors.affiliation: Division of Rheumatology, Allergy Immunology, University of California San Diego, USA.
authors.forename: Arthur
authors.initials: A
authors.lastname: Kavanaugh
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D001688:Biological Products / Q000627:therapeutic use; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D017410:Practice Guidelines as Topic
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D007166:Immunosuppressive Agents; D008727:Methotrexate